SG11201601939VA - Method - Google Patents

Method

Info

Publication number
SG11201601939VA
SG11201601939VA SG11201601939VA SG11201601939VA SG11201601939VA SG 11201601939V A SG11201601939V A SG 11201601939VA SG 11201601939V A SG11201601939V A SG 11201601939VA SG 11201601939V A SG11201601939V A SG 11201601939VA SG 11201601939V A SG11201601939V A SG 11201601939VA
Authority
SG
Singapore
Application number
SG11201601939VA
Inventor
Sai Kiang Lim
Original Assignee
Agency Science Tech & Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agency Science Tech & Res filed Critical Agency Science Tech & Res
Priority to SG11201601939VA priority Critical patent/SG11201601939VA/en
Publication of SG11201601939VA publication Critical patent/SG11201601939VA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/001—Preparations to induce tolerance to non-self, e.g. prior to transplantation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
SG11201601939VA 2013-09-16 2014-09-15 Method SG11201601939VA (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SG11201601939VA SG11201601939VA (en) 2013-09-16 2014-09-15 Method

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SG2013069661 2013-09-16
PCT/SG2014/000434 WO2015038075A1 (en) 2013-09-16 2014-09-15 Method
SG11201601939VA SG11201601939VA (en) 2013-09-16 2014-09-15 Method

Publications (1)

Publication Number Publication Date
SG11201601939VA true SG11201601939VA (en) 2016-04-28

Family

ID=52666048

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201601939VA SG11201601939VA (en) 2013-09-16 2014-09-15 Method

Country Status (4)

Country Link
US (2) US20160220613A1 (en)
JP (1) JP6633056B2 (en)
SG (1) SG11201601939VA (en)
WO (1) WO2015038075A1 (en)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10640464B2 (en) 2011-01-03 2020-05-05 The William M. Yarbrough Foundation Use of isothiocyanate functional surfactants as Nrf2 inducers to treat epidermolysis bullosa simplex and related diseases
GB201202319D0 (en) 2012-02-10 2012-03-28 Orbsen Therapeutics Ltd Stromal stem cells
PL2972193T3 (en) 2013-03-13 2020-08-24 University Of Miami Method for isolation and purification of microvesicles from cell culture supernatants and biological fluids
CN105324391A (en) 2013-04-16 2016-02-10 奥尔布森治疗学有限公司 Medical use of syndecan-2
MX2016009771A (en) 2014-01-31 2016-11-14 Factor Bioscience Inc Methods and products for nucleic acid production and delivery.
JP6773563B2 (en) 2014-05-18 2020-10-21 ザ チルドレンズ メディカル センター コーポレーション Methods and compositions related to exosomes
CN107106614A (en) * 2014-09-15 2017-08-29 新加坡科技研究局 Graft versus host disease(GVH disease) is treated with excretion body（GVHD）Or epidermolysis bollosa（EB）Method
WO2016131052A1 (en) 2015-02-13 2016-08-18 Factor Bioscience Inc. Nucleic acid products and methods of administration thereof
JP6920207B2 (en) 2015-03-20 2021-08-18 オルブセン セラピューティクス リミテッド Cindecan-2 modulator and its use
CN108697740A (en) * 2015-11-18 2018-10-23 佐治亚大学研究基金会 The outer vesica of nerve cell
US11918687B2 (en) 2016-01-15 2024-03-05 Orbsen Therapeutics Limited SDC-2 exosome compositions and methods of isolation and use
US11161902B2 (en) * 2016-05-09 2021-11-02 Helmholtz Zentrum Muenchen—Deutsches Forschungszentrum Fuer Gesundheit Und Umwelt (Gmbh) Tissue-specific exosomes as biomarkers
ES2925527T3 (en) * 2016-08-14 2022-10-18 Univ Ramot Exosomes derived from mesenchymal cells to treat neurological disorders
WO2018035377A1 (en) 2016-08-17 2018-02-22 Factor Bioscience Inc. Nucleic acid products and methods of administration thereof
CN107217034A (en) * 2017-04-20 2017-09-29 深圳市赛欧细胞生物科技有限公司 A kind of human umbilical cord mesenchymal stem cells source excretion body and its acquisition methods and application
CN106913583A (en) * 2017-04-20 2017-07-04 深圳市赛欧细胞生物科技有限公司 The preparation method and application of human mesenchymal stem cell source excretion body biologically active agents
AU2018300272A1 (en) 2017-07-14 2020-02-06 Orbsen Therapeutics Limited CD39 stromal stem cells methods of isolation and use
EP3668319A4 (en) * 2017-08-15 2021-05-19 Children's Medical Center Corporation Purified mesenchymal stem cell exosomes and uses thereof
EP3672606A4 (en) * 2017-08-24 2021-05-05 The Texas A & M University System Mesenchymal stem/stromal cell-derived extracellular vesicles and uses thereof in autoimmune diseases
JP2020534344A (en) * 2017-09-22 2020-11-26 ユニバーシティ オブ マイアミ Methods and compositions for treating epidermolysis bullosa
AU2018394238A1 (en) * 2017-12-28 2020-06-18 Lonza Sales Ag Exosomes for immuno-oncology and anti-inflammatory therapy
CN112334190A (en) * 2018-04-30 2021-02-05 儿童医学中心公司 Mesenchymal stromal cell exosomes and uses thereof
WO2019213501A1 (en) * 2018-05-04 2019-11-07 Spinalcyte, Llc De-differentiated fibroblast-conditioned media for stimulation of disc regeneration
CN108823159B (en) * 2018-07-13 2022-08-09 上海齐昔生物科技集团有限公司 Effect of PDGF-BB on exosomes released by mesenchymal Stem cells
EP3598978A1 (en) 2018-07-26 2020-01-29 EXOFIX S.r.l. Fibroadipogenic progenitor-derived exosomes for regeneration of dystrophic muscles
CN108703938A (en) * 2018-08-07 2018-10-26 深圳市莱利赛生物科技有限公司 A kind of facial mask containing mescenchymal stem cell excretion body extract
TWI722400B (en) * 2019-03-18 2021-03-21 佛教慈濟醫療財團法人 Mesenchymal stem cell derived exosomes and uses thereof
US10501404B1 (en) 2019-07-30 2019-12-10 Factor Bioscience Inc. Cationic lipids and transfection methods
KR102497346B1 (en) * 2021-11-11 2023-02-06 재단법인 자생의료재단 Composition for enhancing immunity comprising exosome derived from antlers

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110003008A1 (en) * 2008-02-22 2011-01-06 Agency For Science, Technology And Research (A*Star) Mesenchymal stem cell particles
EP2629782B1 (en) * 2010-10-18 2019-02-20 Agency For Science, Technology And Research Use of exosomes derived from mesenchymal stem cells to promote or enhance hair growth
SG183579A1 (en) * 2011-02-11 2012-09-27 Agency Science Tech & Res Methods of detecting therapeutic exosomes
EP2850178A4 (en) * 2012-05-18 2015-10-28 Agency Science Tech & Res Umbilical cord mesenchymal stem cell exosomes
EP2687219A1 (en) * 2012-07-18 2014-01-22 Universität Duisburg-Essen Use of preparations comprising exosomes derived from mesenchymal stem cells (MSCs) in the prevention and therapy of inflammatory conditions
CN103767985A (en) * 2012-10-22 2014-05-07 吉林省霍普金斯药物研究院有限责任公司 Preparation and application of exosome secreted by human derived blood or mesenchymal stem cell

Also Published As

Publication number Publication date
US20170258845A1 (en) 2017-09-14
WO2015038075A1 (en) 2015-03-19
US20160220613A1 (en) 2016-08-04
JP2017526723A (en) 2017-09-14
JP6633056B2 (en) 2020-01-22

Similar Documents

Publication Publication Date Title
SG11201601939VA (en) Method
GB201314695D0 (en) Method
GB201318465D0 (en) Method
GB201320351D0 (en) Method
GB201309057D0 (en) Method
GB201316744D0 (en) Method
GB201309928D0 (en) Method
GB201316849D0 (en) Method
GB201301857D0 (en) Method
GB201313249D0 (en) Method
GB201309654D0 (en) Method
GB201301233D0 (en) Method
GB201300409D0 (en) Method
GB201311385D0 (en) Method
GB201305714D0 (en) Method
GB201301094D0 (en) Method
GB201314054D0 (en) Method
GB201312609D0 (en) Method
GB201311389D0 (en) Method
GB201322768D0 (en) Method
GB201320660D0 (en) Method
GB201319361D0 (en) Method
GB201318830D0 (en) Method
GB201318490D0 (en) Method
GB201317970D0 (en) Method